Prof. Dr. Brenda A. Schulman
Career
Brenda Schulman’s lab is recognized for illuminating mechanisms of ubiquitin and ubiquitin-like protein ligation, and for using a distinctive biochemical reconstitution approach to identify novel in vivo regulatory pathways. Schulman received her Ph.D. from M.I.T. and did postdoctoral training at MGH Cancer Center and Memorial Sloan-Kettering Cancer Center. She started her lab at St. Jude Children’s Research Hospital in 2001, where she was an Investigator of the Howard Hughes Medical Institute, and the Joseph Simone Chair in Basic Research, and retains an adjunct faculty position.
Schulman became a full-time Director and Scientific Member at the Max Planck Institute of Biochemistry in 2017. Schulman was elected to the American Academy of Arts and Sciences in 2012, the National Academy of Sciences in 2014, EMBO in 2018, the German Academy Leopoldina in 2019, and recently received the 2019 Gottfried Wilhelm Leibniz Prize and Ernst Jung Prize for Medicine.
Functions
- Since 2019 Boerhaave Chair Honorary Visiting Professorship, University of Leiden
- Since 2018 Honorary Professor, Technical University of Munich
- Since 2016: Director and Scientific Member at the Max Planck Institute of Biochemistry (primary appointment since 2017, before secondary appointment)
- 2005 – 2017: Investigator, Howard Hughes Medical Institute, USA
- 2001 – 2017: Faculty, St. Jude Children’s Research Hospital, Memphis, TN, USA (since 2017 Adjunct Faculty)